These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23502663)

  • 1. Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs.
    Wongnoi R; Penvieng N; Singboottra P; Kingkeow D; Oberdorfer P; Sirivatanapa P; Pornprasert S
    Indian Pediatr; 2013 Jun; 50(6):567-72. PubMed ID: 23502663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiretroviral drugs for prevention of HIV-mother-to-child transmission on hematological parameters and hemoglobin synthesis in HIV-uninfected newborns with and without thalassemia carrier.
    Wongnoi R; Oberdorfer P; Sirivatanapa P; Phanpong C; Pornprasert S
    Curr HIV Res; 2013 Apr; 11(3):187-92. PubMed ID: 23607655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin.
    Pornprasert S; Wongnoi R; Oberdorfer P; Sirivatanapa P
    Curr HIV Res; 2014; 12(3):227-31. PubMed ID: 25026900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and hematological effects of perinatal exposure to antiretroviral drugs in HIV exposed, non infected children.
    Shah I
    Indian Pediatr; 2013 Jun; 50(6):565-6. PubMed ID: 23942399
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission Program.
    Obumneme-Anyim I; Ibeziako N; Emodi I; Ikefuna A; Oguonu T
    J Trop Pediatr; 2016 Feb; 62(1):3-9. PubMed ID: 26411560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
    Fouché C; van Niekerk E; du Plessis LM
    Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
    Bunders M; Thorne C; Newell ML;
    AIDS; 2005 Jul; 19(10):1071-9. PubMed ID: 15958839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers.
    Simon A; Warszawski J; Kariyawasam D; Le Chenadec J; Benhammou V; Czernichow P; Foissac F; Laborde K; Tréluyer JM; Firtion G; Layouni I; Munzer M; Bavoux F; Polak M; Blanche S;
    JAMA; 2011 Jul; 306(1):70-8. PubMed ID: 21730243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART.
    Ono E; Nunes dos Santos AM; de Menezes Succi RC; Machado DM; de Angelis DS; Salomão R; Kallás EG; de Moraes-Pinto MI
    Braz J Med Biol Res; 2008 Aug; 41(8):700-8. PubMed ID: 18797705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic function in HIV-infection.
    Kolte L
    Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?
    Soler-Palacín P; Martín-Nalda A; Martínez-Gómez X; Melendo S; Riudor E; Arranz JA; Espiau M; Figueras C
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):752-8. PubMed ID: 22010980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to antiretroviral agents during pregnancy does not alter bone status in infants.
    Mora S; Giacomet V; Viganò A; Cafarelli L; Stucchi S; Pivetti V; Manfredini V; Puzzovio M; Zuccotti G
    Bone; 2012 Jan; 50(1):255-8. PubMed ID: 22080170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes.
    Borkowsky W; Krasinski K; Cao Y; Ho D; Pollack H; Moore T; Chen SH; Allen M; Tao PT
    J Pediatr; 1994 Sep; 125(3):345-51. PubMed ID: 7915303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.